AM

AMN Healthcare Services IncNYSE AMN Stock Report

Last reporting period 30 Sep, 2024

Updated 20 Dec, 2024

Last price

Market cap $B

1.598

Small

Exchange

XNYS - New York Stock Exchange, Inc

AMN Stock Analysis

AM

Avoid

Based on Eyestock quantitative analysis, AMN`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

27/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

13.7 %

Undervalued

Market cap $B

1.598

Dividend yield

Shares outstanding

41.066 B

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities across the nation. The company is headquartered in Dallas, Texas and currently employs 4,230 full-time employees. The company went IPO on 2001-11-13. The firm operates through three segments: nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. The nurse and allied solutions segment include the Company’s travel nurse staffing, including international nurse staffing and rapid response nurse staffing; labor disruption staffing; local staffing; international nurse and allied permanent placement; allied staffing and revenue cycle solutions businesses. The physician and leadership solutions segment includes the Company’s locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The technology and workforce solutions segment includes its language services, vendor management systems, workforce optimization, virtual care, credentialing solutions and outsourced solutions businesses.

View Section: Eyestock Rating